Yabao Pharmaceutical Group Co Ltd (600351.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE000001CM5

Price
7.19 CNY
Market cap
4.98 bn CNY
P/E (2025)
15.55
P/S (2025)
2.22
Dividend yield
7.65 %
Net margin
14.29 %
Return on equity (ROE)
11.10 %
Return on assets (ROA)
9.74 %

Yabao Pharmaceutical Group Co Ltd financials

Fiscal year20242025
Revenue2.69 bn CNY2.24 bn CNY
Gross profit1.36 bn CNY1.18 bn CNY
Operating income299.95 m CNY349.71 m CNY
EBIT297.79 m CNY375.91 m CNY
Net income242.69 m CNY320.01 m CNY
Diluted EPS – continuing operations0.34 CNY0.46 CNY

Full history since 1999, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Yabao Pharmaceutical Group Co Ltd

Yabao Pharmaceutical Group Co., Ltd engages in the research and development, production, and sale of pharmaceutical products in China and internationally. It provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, analgesics, psychotropic drugs, women's health products, patches, and general health products. The company was founded in 1978 and is based in Beijing, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.